NCT06762834View on ClinicalTrials.gov

Investigating the Role of Ginger Tea ORAC Value in Hypertension Management

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

March 1, 2025

Conditions
Hypertension
Interventions
COMBINATION_PRODUCT

Ginger tea

determine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.

COMBINATION_PRODUCT

self administred Ginger tea

To identify consumption and its correlation with blood pressure outcomes using a self- reported diary and periodic clinical assessments.

Trial Locations (2)

Unknown

Azra Naheed Medical College, Superior University, Lahore

Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University, Lahore

All Listed Sponsors
lead

Superior University

OTHER

NCT06762834 - Investigating the Role of Ginger Tea ORAC Value in Hypertension Management | Biotech Hunter | Biotech Hunter